Novartis AG Stock price

Equities

NOVN

CH0012005267

Pharmaceuticals

Market Closed - Swiss Exchange 12:30:28 2024-03-28 pm EDT 5-day change 1st Jan Change
87.37 CHF +0.82% Intraday chart for Novartis AG +0.75% +2.95%
Sales 2024 * 48.14B 43.38B Sales 2025 * 50.19B 45.23B Capitalization 210B 189B
Net income 2024 * 10.05B 9.05B Net income 2025 * 11.03B 9.94B EV / Sales 2024 * 4.59 x
Net Debt 2024 * 11.49B 10.36B Net Debt 2025 * 10.14B 9.13B EV / Sales 2025 * 4.38 x
P/E ratio 2024 *
18.6 x
P/E ratio 2025 *
16.5 x
Employees 76,057
Yield 2024 *
3.9%
Yield 2025 *
4.03%
Free-Float 81.95%
More Fundamentals * Assessed data
Dynamic Chart

Latest transcript on Novartis AG

1 day+0.69%
1 week+0.75%
Current month-2.37%
1 month-2.92%
3 months+3.96%
6 months-6.77%
Current year+2.95%
More quotes
1 week
85.85
Extreme 85.85
87.37
1 month
84.79
Extreme 84.79
91.06
Current year
84.79
Extreme 84.79
94.52
1 year
82.72
Extreme 82.72
94.77
3 years
72.84
Extreme 72.84
94.77
5 years
65.09
Extreme 65.09
96.38
10 years
65.09
Extreme 65.09
103.20
More quotes
Managers TitleAgeSince
Chief Executive Officer 48 04-12-31
Director of Finance/CFO 59 02-12-31
Chief Tech/Sci/R&D Officer 62 22-05-15
Members of the board TitleAgeSince
Director/Board Member 62 12-12-31
Director/Board Member 65 20-02-27
Chairman 68 12-12-31
More insiders
Date Price Change Volume
24-03-28 87.37 +0.82% 2 950 907
24-03-27 86.66 +0.59% 2,823,832
24-03-26 86.15 -0.30% 2,390,891
24-03-25 86.41 -0.12% 1,801,019
24-03-22 86.51 -0.24% 2,157,126

Delayed Quote Swiss Exchange, March 28, 2024 at 12:30 pm EDT

More quotes
Novartis AG is one of the world's leaders in the design, manufacturing, and marketing of pharmaceutical products. Net sales (excluding discontinued operations) break down by therapeutic area as follows: - oncology (29.9%); - immunology (17.2%); - cardiovascular, renal and metabolic diseases (14.1%); - neuroscience (8.9%). The remaining net sales (29.9%) are from contract manufacturing of pharmaceutical products. At the end of 2023, Novartis AG had 33 production sites worldwide. Net sales are distributed geographically as follows: Europe (33%), the United States (39.5%), Asia/Africa/Australasia (20.5%), Canada and Latin America (7%).
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
20
Last Close Price
95.72 USD
Average target price
108.4 USD
Spread / Average Target
+13.23%
Consensus
  1. Stock
  2. Equities
  3. Stock Novartis AG - Swiss Exchange